The collagen and gelatin brand Rousselot will spotlight its science-backed collagen solutions at Vitafoods Europe 2026 (stand 3C146), with an exclusive introduction to its new science on targeted collagen peptides for next-generation metabolic support and glucose control.
The company will also present its wider collagen and gelatin portfolio supporting holistic wellbeing and healthier reformulation.
As GLP-1 therapies shake up the nutrition and supplement landscape, Rousselot will spotlight Nextida® GC, a next-generation collagen peptide composition designed to help manage post-meal glucose levels and enhance the body's natural GLP-1 response.
Alongside the opportunity to explore application concepts tailored for trending and emerging consumer needs, such as glucose support, joint support, wellbeing and beauty, visitors can learn from Rousselot experts about the new study into Nextida GC.
The study not only corroborated findings on the enhancement of natural GLP-1 secretion but also demonstrated lower post-meal glucose spikes and improved insulin response, showing significant delayed gastric emptying, another mechanism that helps prevent spikes in blood sugar after eating.
"Innovation in metabolic support must be grounded in strong science," said Lauretta Katsriku, Global Category Leader (H&N) – Collagen at Rousselot.
Our work doesn't stop at launching an ingredient. We remain committed to ongoing research and investment to continuously strengthen the scientific foundation behind Nextida GC, helping our partners bring credible, evidence-based metabolic support solutions to market.
At Vitafoods Europe 2026, visitors can gain in-depth scientific and market insights during two expert-led sessions from Rousselot:
Nextida GC: the newest science behind its metabolic balance benefits
This session will present the latest findings on Nextida GC, including its mechanism of action and the key consumer personas positioned to benefit from natural metabolic support, in two sessions at the show.
Speaker: Dr Catarina Silva
Date: Tuesday, 5 May
Time: 14:30–14:55
Theatre: New Ingredients Theatre (3D258)
Innovating GLP-1 Companions: collagen-based solutions, from protein boost to side-effect support.
This session will highlight how premium collagen ingredients such as Peptan® can strengthen companion nutrition solutions to increase protein intake and even support in side effect mitigation and how Rousselot's collagen portfolio enables versatile, evidence-based concepts across categories.
Speakers: Lauretta Katsriku and Tim de Lange
Date: Wednesday, 6 May
Time: 14:30–14:55
Theatre: New Ingredients Theatre (3D258)
A complete portfolio for in demand health areas
Beyond Nextida GC, Rousselot will additionally showcase the following: Peptan, a premium collagen peptide for holistic wellbeing, supporting beauty, mobility and active lifestyles; Colartix®, a hydrolysed cartilage collagen matrix for joint health applications; and Protake® and Peptinex®, collagen protein solutions designed for enriched nutritional formulations.
The company will also present high-quality gelatin solutions for functional gummies, softgels and hard capsules, combining technical performance with formulation flexibility.
To understand how these ingredients can be enjoyed in everyday routines, visitors will also be able to explore the following range of applications on the stand:
- Nextida GC shots in tropical flavours for convenient metabolic support
- New Peptan flavoured sachets (e.g., cucumber-mint-lime), offering premium solubility and neutral taste for flavour innovation
- Colartix gummies delivering joint support in indulgent confectionery formats
- Peptan concepts in refreshing beverage applications, including carbonated soda-style drinks.
Attendees can visit stand 3C146 at Vitafoods Europe 2026 to discover the latest innovations in collagen and gelatin solutions.